Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

A charity boss who struggled for years to shed pounds despite having undergone surgery has hailed weight-loss jabs as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The study lasts up to five weeks and involves four to five visits to the Center for Human Nutrition. The study involves measuring body composition, sleep, mood, diet and other aspects of health.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

“However, I had an abusive and violent childhood, and I’m still unsure how trauma may affect weight gain. My weight got out of control when I was pregnant with my first child, 36 years ...

As weight loss jabs soar in popularity, many people have turned to online pharmacies and websites to get the medications without having to see a doctor. However, this will change as online pharmacies ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk (NYSE: NVO) is under pressure from investors for more information about its ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed some stones ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro) may ...